LAWIN Advised on the Acquisition of a World Leader in the Discovery of Molecular Biological Products

LAWIN Vilnius office has advised Fermentas International Inc., a world leader in the discovery and manufacture of quality molecular biologicals on its acquisition by Thermo Fisher Scientific Inc. The transaction value was USD 260 million making it the largest deal of its kind in the Baltic States in the last 20 years.

LAWIN partner Gediminas Reciunas led the team of the Lithuanian tax and legal professionals advising Fermentas in what, according to Mr Andrius Kubilius, Lithuania's Prime Minister, was the largest private capital transaction in Lithuania during the last 20 years.

Fermentas International has approximately 500 employees, is headquartered in Burlington, Ontario, Canada, and has principal operations in Vilnius, Lithuania. The company had revenues of approximately USD $55 million in 2009. Fermentas will be integrated into Thermo Fisher Scientific’s Analytical Technologies Segment.

Lideika, Petrauskas, Valiunas ir partneriai LAWIN, has been advising Fermentas for more than a decade and led the company through corporate reorganisations resulting in the establishment of Fermentas International, Inc., a holding company based in Ontario, Canada with subsidiaries in Lithuania, Germany, Canada and the US; subsequent investment by Summit Partners, a leading private equity and venture capital firm based in Boston; and finally realizing the group's value through the sale of Fermentas to Thermo Fisher Scientific Inc.,a world leader in serving science with revenues of more than $10 billion and approximately 35,000 employees.